Regional industry attraction efforts continue despite COVID-19 The coronavirus pandemic will not be stopping the Center for Economic Growth from promoting the Capital Region’s innovation assets and manufacturing capabilities at the nation’s leading semiconductor industry event. Except instead of traveling to San Francisco to attend the 50th annual SEMICON West,
From conducting clinical trials to developing testing equipment and medical devices, the Capital Region’s Life Sciences Cluster is contributing to the effort to fight the coronavirus pandemic. The Life Sciences Cluster employs more than 5,800 and features several industries that are nationally unique. Below is an overview of COVID-19-related activates
Featured R&D projects: MortalityMinder: A Tool for Analyzing County-level Mortality Trends App-Based Device to Accelerate Recovery for Chronic Pain, Other Illnesses Population Health Observatory This edition’s contributors: SUNY Research Foundation | University at Albany | University at Buffalo | Rensselaer Polytechnic Institute MortalityMinder: A Tool for Analyzing County-level Mortality Trends
National Institutes of Health (NIH) awards in the Capital Region climbed to an 11-year high in fiscal 2019, driven by a surge in R&D funding at AMRI, GE Global Research, Rensselaer Polytechnic Institute (RPI) and Albany Medical Center, according to a Center for Economic Growth (CEG) analysis.1 “These NIH awards
Featured R&D projects: AiMOS – Artificial Intelligence Multiprocessing Optimized System A Self-Protecting 5G System Using Quantum Computing Approaches Improving Deepfake Detection Expanding Wireless Technology Where’s Waldo? Identifying Cyberattacks using Low-Level Hardware Information This edition’s contributors: SUNY Research Foundation | SUNY Polytechnic Institute | University at Albany | Clarkson University |
The pharmaceutical industry has started conducting hundreds of clinical trials at Capital Region medical facilities in recent years, and more drug testing is expected as the local Life Sciences Cluster vastly expands with several multimillion-dollar projects. Emerging Clinical Trial Support Assets The pharmaceutical industry funded 342 clinical trials for drug
R&D spending on life sciences increased by nearly 18 percent to $126.7 million in fiscal 2018. That was a four-year high for local R&D spending in that field, according to a Center for Economic Growth (CEG) analysis of new data from the Nation Center for Science and Engineering Statistics. The
FOR IMMEDIATE RELEASE ALBANY, NEW YORK – The Capital Region Cancer Research group (CRCR) will sponsor a half-day symposium as part of its CRCR New Frontiers Series, entitled “New strategies and technologies in cancer research.” The event will be held on Nov. 1 at the Albany College of Pharmacy and
Featured R&D projects: Startup aims to advance the 3D printing of high-performance ceramics Binghamton to acquire advanced materials research tool Using nanotechnology to optimize ceramics, alloys, and composites Exploring the properties of photonic nanostructures Bio-industrial Materials Institute (BMI): Sustainable Materials Development Mycelium based biocomposites and foams High efficiency fiber reinforced
Times Union By: Larry Rulison Albany- Despite the fact that General Electric Co., GlobalFoundries and companies like SI Group have all downsized their local operations in recent years, the Capital Region is an emerging force when it comes to corporate research and development spending. That’s according to the Center for
